Document is current
Any future updates will be listed below
-
Authors
Ren, Yifei
Chen, Ying
Zheng, Xizi
Wang, Hui
Kang, Xin
Tang, Jiawei
Qu, Lei
Shao, Xiaoyan
Wang, Suxia
Li, Shuangling
Liu, Gang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No.91742205, No.81625004)
Beijing Young Scientist Program (BJJWZYJH01201910001006)
National Major Science and Technology Projects of China (No.2017ZX09304028)
Peking University Clinical Scientist Program by the Fundamental Research Funds for the Central Universities
- License Information
-
More Information
Article History
Received: 11 May 2020
Revised: 16 August 2020
Accepted: 31 August 2020
First Online: 23 September 2020
Ethics approval and consent to participate
: Human amniotic epithelial stem cells were isolated by Shanghai iCELL Biotechnology Co Ltd. from fresh amnion membranes collected from healthy mothers after cesarean deliveries in the International Peace Maternity and Child Health Hospital with written and informed consent. The procedure was approved by the Institutional Ethics Committee of the International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University (Approval Number: [2014]11).All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Peking University First Hospital (Approval Number: J201868).
: Not applicable.
: Li Yang has a patent pending for the use of hAECs in repair of the injured kidney after AKI. Shanghai iCELL Biotechnology company declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The other authors have no financial conflicts of interest.
